Back to Trades
Total Value
$426.4K
Net $426.4K sold
Filing Date
Aug 14, 2025
1 transaction
Sales
$426.4K
1 transaction
Trade Summary
On Aug 12, 2025, Rowland Thomas Andrew, SVP, HEAD - ESTABLISHED BRANDS, sold $426.4K of ANI PHARMACEUTICALS INC (ANIP) across 1 transaction. The filing covers Common Stock and reflects net selling of $426.4K. Reported prices ranged from $85.71. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- ANI PHARMACEUTICALS INC
- Ticker Symbol
- ANIP
- CIK
- 0001023024
Insider Information
- Role
- SVP, HEAD - ESTABLISHED BRANDS
- Location
- BAUDETTE, MN
Filing Details
- Filing Date
- Aug 14, 2025
- Transaction Date
- Aug 12, 2025
- Accession Number
- 0001507496-25-000007
- Form Type
- 4
- Net Trading Amount
- -$426.4K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Aug 12, 2025 | Common Stock | 4,975 | $85.71 | Sale | $426.4K |
Want live alerts when Rowland Thomas Andrew trades again?
Download Insider Trades to track ANIP, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)The shares were sold in multiple trades at prices ranging from $85.52 to $86.22. The price reported above reflects the weighted average sales price.
- (F2)Includes 304 shares of ANI Pharmaceuticals, Inc. Common Stock that were acquired under the ANI Pharmaceuticals, Inc. Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(d) and Rule 16b-3(c).